Log In
BCIQ
Print this Print this
 

YKP1447

  Manage Alerts
Collapse Summary General Information
Company SK Biopharmaceuticals Co. Ltd.
DescriptionSelective serotonin's 5-HT2A, 5-HT2C, D2 and D3 receptor antagonist
Molecular Target Serotonin (5-HT) receptor ; Dopamine receptor
Mechanism of ActionDopamine receptor antagonist; Serotonin (5-HT) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today